BioSpace News Archive

Deals

Guangdong Lewwin Pharmaceutical Research Institute Selects Provantis Preclinical Software Solution

Instem announced today that Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. has purchased the Provantis preclinical software solution suite to manage preclinical processes at the Center for Drug Non-clinical Evaluation and Research of Guangdong Institute of Applied Biological Resources in Guangdong, Southern China.

January 8, 2018
·
4 min read
Safety of Intravenous Administration of Biostar’s Cultured Stem Cells was Proven: No Possibility of Cancer Occurrence from Multiple Infusions

A clinical study on safety found that multiple intravenous administrations of cultured human autologous adipose-derived stem cells which were cultured by Biostar Stem Cell Research Institute do not affect the incidence of cancer in human subjects.

January 8, 2018
·
4 min read
Pharm Country

Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250M

Royalty Pharma has also purchased $75 million in common stock of Immunomedics.

January 8, 2018
·
6 min read
Business

ChemoCentryx Strengthens Senior Executive Team With the Appointment of William Fairey as Executive Vice President and Chief Operating Officer

Mr. Fairey brings to ChemoCentryx over 25 years of substantial pharmaceutical industry commercial experience.

January 8, 2018
·
5 min read
Business

CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results

The company reported preliminary financial results for the fourth quarter and full year ended December 31, 2017.

January 8, 2018
·
4 min read
Drug Development

Novaliq Announces First Patient Enrolled in Its SEECASE Phase II Trial of NOV03 for the Treatment of Dry Eye Disease

Novaliq announced that it has begun randomization of patients in its SEECASE Phase 2 clinical trial for the treatment of dry eye disease (DED).

January 8, 2018
·
3 min read
Business

Perosphere Pharmaceuticals Appoints Robert S. Langer, Sc.D. to its Board of Directors

Perosphere Pharmaceuticals Inc. announced today that it has appointed Robert S. Langer, Sc.D., founding Chairman of Perosphere’s Scientific Advisory Board and Institute Professor, MIT, to its Board of Directors.

January 8, 2018
·
2 min read
Business

Germany’s Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts

As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States.

January 8, 2018
·
3 min read
Pharm Country

Celgene Corporation Announces Preliminary 2017 Unaudited Results and 2018 Financial Guidance

Celgene today provided a business update as well as its preliminary 2017 unaudited results and financial guidance for 2018 at the 36th Annual J.P. Morgan Healthcare Conference.

January 8, 2018
·
21 min read
FDA

Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)

TransAeris is a temporary diaphragm stimulator, for use in intensive care unit (ICU) patients on mechanical ventilation (MV).

January 8, 2018
·
2 min read